Private Equity Hospital Acquisitions and Patient Experience, Asthma Endotyping Using Nasal Epithelium, Bird Flu Update, and more
Jan 10, 2025
auto_awesome
Discover the impact of private equity on hospital care experiences and new findings on asthma subtypes in youth. Explore treatment disparities in pediatric asthma and diabetes management, along with innovations in patient communication. Learn about the risks of predatory journals and the latest advances in women's health research. Get vital updates on pneumonia and bird flu threats, as well as how AI is being utilized for early warning in healthcare and suicide risk identification.
The decline in patient-reported ratings after private equity acquisitions signals potential adverse effects on healthcare quality and patient experience.
The study on asthma endotyping reveals a predominance of T2 low profiles in diverse youth populations, challenging previous assumptions about asthma characteristics.
Deep dives
Impact of Private Equity on Hospital Care Experience
A study examined the patient-reported care experience in U.S. hospitals that have been acquired by private equity firms. The research compared 73 private equity-acquired hospitals to 293 control hospitals based on overall hospital ratings and willingness to recommend. Results indicated a significant decline in patient-reported ratings following the acquisition, with negative perceptions peaking three years post-acquisition. This trend raises concerns about the implications of private equity investments on quality of care in healthcare settings.
Understanding Asthma Subtypes in Youth
Research focused on CD4 T-cell subtypes in school-aged youth with asthma, highlighting the need to better characterize asthma for effective therapy development. The study analyzed nasal epithelial samples from diverse populations, including Puerto Rican and African American youth, who face greater asthma challenges. Findings revealed that most participants had T2 low asthma profiles, contrary to the existing belief that T2 high asthma is dominant. Accounting for factors like prior steroid treatments enhanced the study's reliability and offered new insights into pediatric asthma.
Comparing Treatments for Gestational Diabetes
A randomized trial compared the efficacy of metformin and insulin in treating gestational diabetes among pregnant individuals. Over 800 participants were assigned to receive either medication, with the study focusing on the incidence of infants born large for gestational age. Results showed that 23.9% of infants from the metformin group were classified as large, compared to 19.9% in the insulin group, thus not meeting non-inferiority criteria. The findings suggest that insulin remains the superior treatment option for managing gestational diabetes.
Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from December 28, 2024-January 10, 2025.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode